Related Experiment Video
Updated: Aug 17, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts
Michael A Laflamme1, David Myerson, Jeffrey E Saffitz
1Department of Pathology, University of Washington, Seattle, Washington, USA.
Insights
Adult humans possess extracardiac stem cells that can regenerate heart muscle, but at very low levels. These progenitor cells migrate to damaged myocardium, aiding in heart repair after injury.
Area of Science:
- Cardiology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Human myocardium regeneration has been historically considered minimal.
- Rodent studies suggest extracardiac stem cells, potentially from bone marrow, can repopulate cardiomyocytes post-injury.
Purpose of the Study:
- To investigate the presence and extent of extracardiac progenitor cell activity in the human heart.
- To determine if human hearts exhibit regenerative capabilities via stem cell migration from external sources.
Main Methods:
- Analysis of Y chromosome presence in cardiomyocytes of female allograft hearts transplanted into male patients.
- Evaluation of cardiomyocyte chimerism in relation to allograft rejection status.
Main Results:
- Minute, but detectable, fractions of Y chromosome-positive cardiomyocytes were found in all studied transplanted hearts.
- Host-derived cardiomyocytes constituted a mean of 0.04% and a median of 0.016% of the total.
- Higher percentages of host-derived cardiomyocytes were observed in areas of acute rejection, particularly in a patient with severe allograft rejection (up to 29% in "hot spots").
Conclusions:
- Adult humans possess extracardiac progenitor cells capable of migrating to and repopulating damaged human myocardium.
- This cardiac regeneration process occurs at very low levels but is associated with myocardial injury and rejection.
Abstract:
Human myocardium has long been considered to have essentially no intrinsic regenerative capacity. Recent studies in rodent models, however, have suggested the presence of an extracardiac stem cell population, perhaps in bone marrow, that is capable of some reconstitution of cardiomyocytes after injury. To determine whether similar mechanisms exist in the human heart, we evaluated human female allograft hearts transplanted into male patients. The presence of Y chromosomes in cardiomyocytes would indicate these cells arose from the recipient, rather than the donor heart. We identified 5 male patients who had retained a female heart at least 9 months before death and necropsy. Remarkably, in each case, the transplanted heart contained a minute but readily detectable fraction of Y chromosome-positive cardiomyocytes. The mean percentage of cardiomyocytes arising from the host was estimated to be 0.04% with a median of 0.016%. Most Y-positive cardiomyocytes were associated with regions of acute rejection, suggesting such chimerism involves an injury event. Furthermore, the sole patient whose immediate cause of death was allograft rejection showed a much higher percentage of host-derived cardiomyocytes, up to 29% in local, 1-mm(2) "hot spots." Thus, adult humans have extracardiac progenitor cells capable of migrating to and repopulating damaged myocardium, but this process occurs at very low levels.

